poisar

Stocks · News reference

Vaxcyte Reports Third Quarter 2026 Financial Results

Fiscal.ai

Vaxcyte, Inc. announced its financial results for the third quarter ended September 30, 2026, and provided a business update.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Vaxcyte, Inc. (PCVX)

    Filed: 2026-10-09 AccNo: 0001193125-26-419174 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits